Sana Biotechnology Inc at Jefferies Healthcare Conference Transcript
Hi everyone. It's my pleasure to welcome Steve Harr, President and CEO of Sana Biotechnology. This is a standard presentation and we'll have some Q&A at the end.
Thank you. Thanks, everybody, for joining. Thank you, Jefferies for inviting us. And appreciate people online dialing in as well.
So we're going to talk a little today about Sana and what we're up to. And as we do that we will, of course, make forward-looking statements. So we'd ask people to take a look at our 10-Q where we spent a lot of time working through the risk factors.
So the company was really founded under the idea that one of if not the most important transformation that will occur in medicine over the next several decades is the ability to modify genes in new cells as medicines. And we really wanted technologies to go after we thought were some of the most fundamental barriers to making that vision a reality.
So there are two separate platforms that we really focused on at the outset
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |